• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Cleveland Clinic Florida Opens Florida Research and Innovation Center

Share:

July 15, 2020

Highlights on this story:
  • Cleveland Clinic Florida opens Florida Research and Innovation Center that will advance innovative translational research, focused on immuno-oncology and infectious diseases, including COVID-19.
  • The 107,000-square-foot, state-of-the-art research facility features modern laboratory space, biosafety level 3 facilities for work with infectious agents, and office space for support services on eight acres of land.

Cleveland Clinic Florida announced the open of the Florida Research and Innovation Center in Port St. Lucie, Florida that will advance innovative translational research, focused on immuno-oncology and infectious diseases, including COVID-19. The Florida Research and Innovation Center will be closely integrated with Cleveland Clinic’s new Center for Global and Emerging Pathogens Research established in April 2020, which has brought together some of the world’s top research experts in virology, immunology, genomics, and population health to broaden understanding of emerging pathogens – ranging from the Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines. The researchers will also collaborate with drug developers at Lerner Research Institute’s Center for Therapeutics Discovery to more rapidly move discoveries out of the laboratory and into the clinic for patient care.

State of the Art Research Facility

Cleveland Clinic Florida Opens Florida Research and Innovation Center
The 107,000-square-foot, state-of-the-art research facility features modern laboratory space, biosafety level 3 facilities for work with infectious agents, and office space for support services on eight acres of land. Cleveland Clinic has recruited a team of renowned scientists to the Florida Research and Innovation Center to launch scientific programs that address both local and international health challenges, including cancer and emerging pathogens. The facility will additionally provide an exceptional training environment for researchers. Philanthropic funding of this research program will support the new center’s efforts to explore new treatments and technology.

Leadership

The Florida Research and Innovation Center is headed by Scientific Director Michaela Gack, Ph.D., who joined Cleveland Clinic Florida in July 2020. Previously, she was a professor in the Department of Microbiology and chair of the Committee on Microbiology at The University of Chicago in Chicago, Ill. Gack, a renowned virologist, has an extensive background in microbiology and infectious disease. Her research focuses on the immune system’s response to viruses, an essential step in developing safe and effective antivirals and vaccines. She has also done extensive research on immune evasion by Dengue, Influenza and Zika viruses.

Research Expansion

The Florida Research and Innovation Center will complement and expand research underway at the Florida health system’s five hospitals and the Lerner Research Institute, which is home to 190 laboratories on Cleveland Clinic’s main campus in Cleveland, Ohio. The scientific teams will closely collaborate, tapping into resources at both facilities to develop new treatments for patients around the globe.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We are pleased to be moving forward with our vision to create a world-class research program in Florida,” said Joseph Iannotti, M.D., Ph.D., Interim CEO and President of Cleveland Clinic Florida and Chief Academic and Innovation Officer. “We are confident that the collaboration between our scientists and partners will ultimately result in the development of therapies that address some of the most challenging medical conditions we face.”

“Cleveland Clinic’s robust research infrastructure will be further expanded with the opening of the Florida Research and Innovation Center,” said Tom Hamilton, Ph.D., vice chair of Cleveland Clinic’s Lerner Research Institute. “Through team-based discovery, forward-thinking science, translational research, clinical trials and innovation, our vision is to bring together a world-class team of experts within a leading-edge research facility.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Ensuring people have equal access to digital health informationEnsuring people have equal access to digital health information
  • Merck to Acquire OncoImmuneMerck to Acquire OncoImmune
  • Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger AgreementPluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement
  • Agiliti Acquires Mobile Instrument Service & Repair, Inc.Agiliti Acquires Mobile Instrument Service & Repair, Inc.
  • Luminopia Scores FDA De Novo for VR Treatment for Lazy EyeLuminopia Scores FDA De Novo for VR Treatment for Lazy Eye
  • Why Pharmaceutical R&D Global Spending Could Exceed $200 Billion By 2024Why Pharmaceutical R&D Global Spending Could Exceed $200 Billion By 2024
  • PwC Report Sees Pharma-Biotech Deals ‘To be Extremely Active in 2020’PwC Report Sees Pharma-Biotech Deals ‘To be Extremely Active in 2020’
  • Walgreens Expands in Primary Care with Starling Physicians’ AcquisitionWalgreens Expands in Primary Care with Starling Physicians’ Acquisition

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications